QuantumSi is trading 10.08% up at $1.20 on October 20, 2026, amid a sector-led biotech move; no clear company-specific announcement explains the gain. - The sector backdrop includes Merck KGaA’s agreement to acquire Silence Therapeutics and positive clinical-trial results elsewhere in biotech. - Quantum-Si’s latest listed releases are its October 16 earnings-date announcement and October 15 Nasdaq-compliance update; neither was published October 20.